Gastrointestinal cancers in China, the USA, and Europe.

Yumo Xie, Lishuo Shi, Xiaosheng He, Yanxin Luo
Author Information
  1. Yumo Xie: Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  2. Lishuo Shi: Center for Clinical Research, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  3. Xiaosheng He: Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  4. Yanxin Luo: Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Abstract

Gastrointestinal (GI) cancers, including colorectal cancer, gastric cancer, and esophageal cancer, are a major medical and economic burden worldwide and have the largest number of new cancer cases and cancer deaths each year. Esophageal and gastric cancers are most common in developing countries, while colorectal cancer forms the major GI malignancy in Western countries. However, a great shift in the predominant GI-cancer type is happening in countries under economically transitioning and, at the same time, esophageal and gastric cancers are reigniting in Western countries due to the higher exposure to certain risk factors. The development of all GI cancers is highly associated with lifestyle habits and all can be detected by identified precancerous diseases. Thus, they are all suitable for cancer screening. Here, we review the epidemiological status of GI cancers in China, the USA, and Europe; the major risk factors and their distribution in these regions; and the current screening strategies.

Keywords

References

  1. CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32 [PMID: 26808342]
  2. Neoplasia. 2004 Sep-Oct;6(5):449-56 [PMID: 15548353]
  3. J Natl Cancer Inst. 2010 Jul 21;102(14):1012-22 [PMID: 20587792]
  4. N Engl J Med. 2001 Sep 13;345(11):784-9 [PMID: 11556297]
  5. Eur J Cancer Prev. 2018 Mar;27(2):124-133 [PMID: 27560662]
  6. Clin Gastroenterol Hepatol. 2016 Mar;14(3):338-347.e1 [PMID: 26484704]
  7. J Natl Cancer Inst. 2006 Oct 18;98(20):1445-52 [PMID: 17047193]
  8. Int J Cancer. 2012 Sep 15;131(6):E963-73 [PMID: 22392502]
  9. Am J Gastroenterol. 2014 Jun;109(6):822-7 [PMID: 24751582]
  10. Eur J Gastroenterol Hepatol. 2010 Jun;22(6):669-78 [PMID: 19474750]
  11. Histopathology. 2020 Jan;76(2):182-188 [PMID: 31433515]
  12. Ann Epidemiol. 2013 Dec;23(12):762-770.e1 [PMID: 24176821]
  13. Nutr Diabetes. 2011 May 09;1:e6 [PMID: 23449381]
  14. Int J Cancer. 2009 May 15;124(10):2406-15 [PMID: 19142968]
  15. Zhonghua Zhong Liu Za Zhi. 2002 Jan;24(1):4-8 [PMID: 11977635]
  16. Oncol Rep. 2016 Dec;36(6):3087-3094 [PMID: 27748858]
  17. Dig Dis Sci. 2014 Mar;59(3):664-73 [PMID: 24395380]
  18. Zhonghua Zhong Liu Za Zhi. 2021 Jan 23;43(1):16-38 [PMID: 33472315]
  19. J Natl Cancer Inst. 2017 Aug 1;109(8): [PMID: 28376186]
  20. Asian Pac J Cancer Prev. 2013;14(4):2533-40 [PMID: 23725170]
  21. N Engl J Med. 2006 Feb 16;354(7):684-96 [PMID: 16481636]
  22. Gastroenterology. 2005 Sep;129(3):863-73 [PMID: 16143126]
  23. Gastroenterology. 2012 Feb;142(2):233-40 [PMID: 22062359]
  24. Asian Pac J Cancer Prev. 2014;15(23):10143-9 [PMID: 25556439]
  25. Am J Gastroenterol. 2005 May;100(5):1002-8 [PMID: 15842570]
  26. JAMA. 2008 Dec 17;300(23):2765-78 [PMID: 19088354]
  27. Lancet. 2011 Feb 12;377(9765):557-67 [PMID: 21295846]
  28. Am J Epidemiol. 2008 Jul 1;168(1):105-14 [PMID: 18483122]
  29. Gut. 2011 Aug;60(8):1029-37 [PMID: 21406386]
  30. Gut. 2005 Jun;54(6):764-8 [PMID: 15888780]
  31. Ann Oncol. 2017 Sep 1;28(9):2086-2093 [PMID: 28911061]
  32. Br J Sports Med. 2018 Jul;52(13):826-833 [PMID: 29146752]
  33. Nat Rev Clin Oncol. 2013 Mar;10(3):130-42 [PMID: 23381005]
  34. N Engl J Med. 2013 Sep 5;369(10):954-64 [PMID: 24004122]
  35. Gastroenterology. 2017 May;152(6):1319-1328.e7 [PMID: 28147224]
  36. Recent Results Cancer Res. 2013;191:1-5 [PMID: 22893197]
  37. Ann Oncol. 2011 Apr;22(4):754-760 [PMID: 20860989]
  38. Gastroenterology. 2016 Apr;150(4):895-902.e5 [PMID: 26677986]
  39. Obes Rev. 2010 Jan;11(1):19-30 [PMID: 19538439]
  40. J Natl Cancer Inst. 2018 Jun 1;110(6):608-615 [PMID: 29361173]
  41. CA Cancer J Clin. 2018 Jul;68(4):250-281 [PMID: 29846947]
  42. J Natl Cancer Inst. 2006 Mar 1;98(5):345-54 [PMID: 16507831]
  43. J Natl Cancer Inst. 2001 Feb 7;93(3):226-33 [PMID: 11158192]
  44. BMJ. 2014 Apr 09;348:g2467 [PMID: 24922745]
  45. Clin Gastroenterol Hepatol. 2014 May;12(5):793-800.e1 [PMID: 24100112]
  46. BMJ. 2009 Mar 26;338:b929 [PMID: 19325180]
  47. Lancet Oncol. 2012 Aug;13(8):790-801 [PMID: 22658655]
  48. Int J Cancer. 2012 Jul 15;131(2):E122-8 [PMID: 22052616]
  49. J Natl Cancer Inst. 2010 May 5;102(9):614-26 [PMID: 20407088]
  50. Nat Rev Cancer. 2004 Aug;4(8):579-91 [PMID: 15286738]
  51. JAMA. 2017 Mar 28;317(12):1234-1243 [PMID: 28350929]
  52. Gastroenterol Rep (Oxf). 2019 Feb;7(1):67-73 [PMID: 30792868]
  53. Ann Oncol. 2018 Apr 1;29(4):825-834 [PMID: 29438474]
  54. Gastroenterology. 2018 Jan;154(2):360-373 [PMID: 28823862]
  55. Int J Cancer. 2007 Jan 1;120(1):128-32 [PMID: 17036324]
  56. Gastroenterol Rep (Oxf). 2019 Aug 13;7(6):379-395 [PMID: 31857901]
  57. Br J Cancer. 2014 Dec 9;111(12):2235-41 [PMID: 25247319]
  58. Gut. 2020 May;69(5):823-829 [PMID: 32001553]
  59. Curr Gastroenterol Rep. 2012 Oct;14(5):428-38 [PMID: 22864806]
  60. Chin J Cancer Res. 2012 Sep;24(3):171-80 [PMID: 23359321]
  61. Lancet. 2010 Nov 20;376(9754):1741-50 [PMID: 20970847]
  62. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907 [PMID: 20647400]
  63. Gut. 2001 Sep;49(3):347-53 [PMID: 11511555]
  64. Gut. 2011 Dec;60(12):1644-9 [PMID: 21613644]
  65. BMC Med. 2014 Oct 10;12:168 [PMID: 25319089]
  66. Am J Gastroenterol. 2017 Aug;112(8):1247-1255 [PMID: 28585555]
  67. N Engl J Med. 2000 Apr 20;342(16):1156-62 [PMID: 10770980]
  68. BMJ. 2014 May 20;348:g3174 [PMID: 24846275]
  69. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1390-8 [PMID: 19383892]
  70. BMC Cancer. 2014 Feb 18;14:103 [PMID: 24548688]
  71. Am J Gastroenterol. 2008 Mar;103(3):510-4 [PMID: 18341483]
  72. Gut. 2015 Mar;64(3):381-7 [PMID: 25320104]
  73. Cancer Causes Control. 2015 Sep;26(9):1271-1279 [PMID: 26092381]
  74. Clin Gastroenterol Hepatol. 2013 Apr;11(4):382-8 [PMID: 23200977]
  75. Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51 [PMID: 26526079]
  76. Gastroenterology. 2015 Oct;149(5):1177-1190.e3 [PMID: 26216840]
  77. Cancer Res Treat. 2018 Apr;50(2):582-589 [PMID: 28602053]
  78. J Natl Cancer Inst. 2015 Aug 01;107(10): [PMID: 26232761]
  79. Aliment Pharmacol Ther. 2010 Nov;32(10):1222-7 [PMID: 20955441]
  80. Gut. 2008 Feb;57(2):173-80 [PMID: 17932103]
  81. CA Cancer J Clin. 2013 Jul-Aug;63(4):232-48 [PMID: 23818335]
  82. Lancet. 2008 Aug 2;372(9636):392-7 [PMID: 18675689]
  83. Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-732 [PMID: 31455888]
  84. Gastroenterology. 2003 Jan;124(1):47-56 [PMID: 12512029]
  85. Gut. 2017 Apr;66(4):683-691 [PMID: 26818619]
  86. Cancer Causes Control. 2008 Sep;19(7):689-701 [PMID: 18293090]
  87. Clin Gastroenterol Hepatol. 2017 Aug;15(8):1256-1264 [PMID: 28130150]
  88. Ann Oncol. 2012 Dec;23(12):3155-3162 [PMID: 22847812]
  89. N Engl J Med. 1999 Mar 18;340(11):825-31 [PMID: 10080844]
  90. BMJ. 2017 Jun 21;357:j2765 [PMID: 28637656]
  91. Lancet Glob Health. 2015 Mar;3(3):e132-42 [PMID: 25701991]
  92. Ann Oncol. 2013 Mar;24(3):609-17 [PMID: 22898040]
  93. Gastroenterology. 2010 Jul;139(1):73-83; quiz e11-2 [PMID: 20399210]
  94. Gut. 2013 May;62(5):676-82 [PMID: 22698649]
  95. Ann Oncol. 2015 Jun;26(6):1101-1109 [PMID: 25480876]
  96. Gut. 2017 Jan;66(1):6-30 [PMID: 27707777]
  97. Int J Cancer. 2014 Oct 15;135(8):1940-8 [PMID: 24623471]
  98. N Engl J Med. 2006 Jun 1;354(22):2340-8 [PMID: 16738270]
  99. Gastroenterology. 2015 May;148(6):1244-60.e16 [PMID: 25575572]
  100. Trends Cancer. 2017 Jun;3(6):423-441 [PMID: 28718417]
  101. CA Cancer J Clin. 2018 May;68(3):217-231 [PMID: 29485237]
  102. Ann Oncol. 2012 Sep;23(9):2319-2326 [PMID: 22351741]
  103. J Natl Cancer Inst. 2006 Oct 18;98(20):1432-4 [PMID: 17047185]
  104. Gut. 2014 Jan;63(1):7-42 [PMID: 24165758]
  105. Gastroenterology. 2011 Jul;141(1):80-9 [PMID: 21473867]
  106. J Natl Cancer Inst. 2007 Apr 4;99(7):545-57 [PMID: 17405999]
  107. Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1395-408 [PMID: 23697611]
  108. J Natl Cancer Inst. 2012 Mar 21;104(6):488-92 [PMID: 22271764]
  109. J Natl Cancer Inst. 2009 Feb 18;101(4):256-66 [PMID: 19211452]
  110. Gastroenterology. 2017 Aug;153(2):420-429 [PMID: 28456631]
  111. Public Health Rev. 2018 Mar 02;39:7 [PMID: 29507820]
  112. Clin Gastroenterol Hepatol. 2009 Dec;7(12):1299-304 [PMID: 19523538]
  113. J Clin Oncol. 2015 Jun 10;33(17):1951-7 [PMID: 25940715]
  114. Am J Gastroenterol. 2017 May;112(5):704-715 [PMID: 28323271]
  115. Int J Cancer. 2013 Jul 15;133(2):473-85 [PMID: 23319052]
  116. J Natl Cancer Inst. 2010 Sep 8;102(17):1344-53 [PMID: 20716718]
  117. Adv Cancer Res. 2019;144:95-135 [PMID: 31349905]
  118. Cancer Epidemiol. 2012 Jun;36(3):306-16 [PMID: 22504051]
  119. N Engl J Med. 2014 Apr 3;370(14):1287-97 [PMID: 24645800]
  120. PLoS One. 2012;7(11):e50041 [PMID: 23209638]
  121. Int J Oncol. 2013 Oct;43(4):973-84 [PMID: 23900573]
  122. Biosci Rep. 2017 Dec 12;37(6): [PMID: 29026008]
  123. Gastroenterology. 2012 Mar;142(3):442-452.e5; quiz e22-3 [PMID: 22108196]
  124. Ann Oncol. 2011 Sep;22(9):1958-1972 [PMID: 21307158]
  125. Immunity. 2019 Nov 19;51(5):794-811 [PMID: 31747581]
  126. JAMA. 2016 Jun 21;315(23):2564-2575 [PMID: 27304597]
  127. N Engl J Med. 2012 Feb 23;366(8):687-96 [PMID: 22356322]
  128. Gastroenterology. 2018 Aug;155(2):347-354.e9 [PMID: 29723507]
  129. CA Cancer J Clin. 2015 Mar;65(2):87-108 [PMID: 25651787]
  130. Princess Takamatsu Symp. 1985;16:29-40 [PMID: 3916200]
  131. BMJ. 2019 Nov 13;367:l6109 [PMID: 31722884]
  132. Gastroenterology. 2012 Aug;143(2):375-81.e1; quiz e13-4 [PMID: 22522090]
  133. Addiction. 2009 Sep;104(9):1487-500 [PMID: 19686518]
  134. Gut. 2012 Sep;61(9):1261-8 [PMID: 22174193]
  135. CA Cancer J Clin. 2018 Nov;68(6):394-424 [PMID: 30207593]
  136. N Engl J Med. 2014 Dec 25;371(26):2499-509 [PMID: 25539106]
  137. Jpn J Clin Oncol. 2018 Jul 01;48(7):673-683 [PMID: 29889263]
  138. Gastroenterology. 2007 Aug;133(2):403-11 [PMID: 17681161]
  139. Gut. 2012 Oct;61(10):1390-7 [PMID: 22190483]
  140. Gastroenterology. 2010 Jun;138(6):2044-58 [PMID: 20420945]
  141. PLoS Med. 2015 Jan 29;12(1):e1001780 [PMID: 25634542]
  142. Arch Iran Med. 2013 Aug;16(8):483-6 [PMID: 23906255]
  143. Carcinogenesis. 2011 Jun;32(6):787-95 [PMID: 21436188]
  144. World J Gastroenterol. 2014 Dec 14;20(46):17288-96 [PMID: 25516639]
  145. Eur J Cancer Prev. 2017 Mar;26(2):119-124 [PMID: 26886238]
  146. J Natl Cancer Inst. 2018 Sep 1;110(9):935-941 [PMID: 29860428]
  147. Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):905-15 [PMID: 22499775]
  148. Am J Gastroenterol. 2011 Mar;106(3):432-42 [PMID: 20978481]
  149. Int J Epidemiol. 2016 Jun;45(3):871-83 [PMID: 26403814]
  150. JAMA Oncol. 2016 Jun 1;2(6):762-9 [PMID: 26940135]
  151. CA Cancer J Clin. 2008 May-Jun;58(3):130-60 [PMID: 18322143]
  152. Gut. 2014 Aug;63(8):1229-37 [PMID: 24221456]
  153. Nat Rev Dis Primers. 2017 Jun 01;3:17036 [PMID: 28569272]
  154. Int J Cancer. 2013 Aug 1;133(3):653-9 [PMID: 23364866]

Word Cloud

Created with Highcharts 10.0.0cancercancersGIgastriccountriescolorectalesophagealmajorscreeningGastrointestinalWesternriskfactorsChinaUSAEuropeincludingmedicaleconomicburdenworldwidelargestnumbernewcasesdeathsyearEsophagealcommondevelopingformsmalignancyHowevergreatshiftpredominantGI-cancertypehappeningeconomicallytransitioningtimereignitingduehigherexposurecertaindevelopmenthighlyassociatedlifestylehabitscandetectedidentifiedprecancerousdiseasesThussuitablereviewepidemiologicalstatusdistributionregionscurrentstrategiesepidemiology

Similar Articles

Cited By